Your browser doesn't support javascript.
loading
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
Russo, A; Incorvaia, L; Capoluongo, E; Tagliaferri, P; Gori, S; Cortesi, L; Genuardi, M; Turchetti, D; De Giorgi, U; Di Maio, M; Barberis, M; Dessena, M; Del Re, M; Lapini, A; Luchini, C; Jereczek-Fossa, B A; Sapino, A; Cinieri, S.
Affiliation
  • Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy. Electronic address: antonio.russo@usa.net.
  • Incorvaia L; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Capoluongo E; Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Naples, Italy; Department of Clinical Pathology- Cannizzaro Hospital, Catania, Italy.
  • Tagliaferri P; Medical and Translational Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
  • Gori S; Department of Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Italy.
  • Cortesi L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Genuardi M; University Hospital Foundation "A. Gemelli", IRCCS - Medical Genetics Unit, Rome, Italy; Section of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University Sacro Cuore, Rome, Italy.
  • Turchetti D; Department of Medical and Surgical Sciences, Center for Studies on Hereditary Cancer, University of Bologna, Bologna, Italy; Unit of Medical Genetics, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Di Maio M; Department of Oncology, University of Turin, Division of Medical Oncology, Ordine Mauriziano Hospital, Turin, Italy.
  • Barberis M; Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Dessena M; S.C. Experimental Surgery, Oncology Hospital, Brotzu Hospital, Cagliari, Italy.
  • Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
  • Lapini A; Department of Urology, University of Florence, University Hospital of Florence, Florence, Italy.
  • Luchini C; Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy; ARC-Net Research Center, University and Hospital Trust of Verona, Verona, Italy.
  • Jereczek-Fossa BA; Division of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Sapino A; Candiolo Cancer Institute, FPO-IRCCS Candiolo, Candiolo, Italy; Department of Medical Sciences, University of Torino, Torino, Italy.
  • Cinieri S; Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy.
ESMO Open ; 7(3): 100459, 2022 06.
Article in En | MEDLINE | ID: mdl-35597177

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Pancreatic Neoplasms / Prostatic Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Pancreatic Neoplasms / Prostatic Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Year: 2022 Type: Article